Prostaglandin release and luteolysis associated with physiological and pathological conditions of the reproductive cycle of the mare: a review
Authors:
- 1 August 1989
- journal article
- review article
- Published by Wiley in Equine Veterinary Journal
- Vol. 21 (S8) , 29-34
Abstract
Summary: The advent of radioimmunoassay for the major metabolite of prostaglandin F 2α (PGF 2α ), 15‐keto‐13, 14‐dihydro‐PGF 2α (15‐ketodihydro‐PGF 2α ), has allowed the dynamics of PGF 2α , secretion to be studied in a variety of physiological and pathological situations in domestic animals, including the mare. In the non‐pregnant cyclic mare, PGF 2α is responsible for the regression of the corpus luteum. In the pregnant mare, pulsatile secretion of PGF 2α is blocked by the presence of the conceptus and the corpus luteum continues to secrete progesterone, essential to the support of pregnancy. At term, the massive increase in PGF 2α synthesis is the major stimulus for uterine contractions during delivery. The endometrium of the non‐pregnant mare secretes PGF 2α in response to inflammatory changes caused by bacterial infection, intra‐uterine infusion of saline (low pH) or other irritants; the amount of PGF 2α released is often sufficient to initiate luteolysis. In the pregnant mare, stimuli that can initiate PGF 2α secretion by the endometrium include uterine and cervical manipulation, chronic uterine inflammation, surgical manipulation of the uterus in conjunction with removal of one of twin conceptuses and manual rupture of one embryonic vesicle per rectum in mares carrying twins. Prostaglandin F 2α can be released by tissues other than the uterus. Systemic administration of endotoxin will induce the synthesis and release of PGF 2α . The secretion of PGF 2α in this situation can result in a decrease of luteal function or complete luteolysis in both the non‐pregnant and pregnant mare. In mares less than 55 days pregnant, compromised luteal activity following the administration of endotoxin results in death of the conceptus. Ongoing studies indicate that flunixin meglumine, a non‐steroidal anti‐inflammatory drug, effectively blocks PGF 2α secretion and can be used to prevent embryonic death in the event of endotoxaemia. Altrenogest can be used as an alternative treatment for the prevention of embryonic death. To be effective, flunixin meglumine must be administered soon after the onset of endotoxaemia whereas altrenogest treatment can be initiated up to 12 h later and still prevent pregnancy loss.Keywords
This publication has 53 references indexed in Scilit:
- Intrauterine inoculation of a bacteria-free filtrate of streptococcus zooepidemicus in clinically normal and infected maresJournal of Equine Veterinary Science, 1985
- Non‐surgical embryo auto‐transfer in the mareEquine Veterinary Journal, 1985
- Dynamic physical interactions between the equine embryo and uterusEquine Veterinary Journal, 1985
- Uterine prostaglandin release relative to embryo collection, transfer procedures and maintenance of the corpus luteumEquine Veterinary Journal, 1985
- Species differences in circulating prostaglandin metabolites relevance for the assay of prostaglandin releaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1982
- Effect of intrauterine infusion of penicillin solution on luteal function in pony mares1981
- Endotoxaemia in the horseEquine Veterinary Journal, 1981
- Low doses of oxytocin can induce foaling at termEquine Veterinary Journal, 1980
- THE OESTROUS CYCLE OF THE MARE AND ITS UTERINE CONTROLAustralian Veterinary Journal, 1977
- Hormonal and related factors affecting the release of prostaglandin F2α from the uterusJournal of Steroid Biochemistry, 1975